California Public Employees Retirement System Has $39.78 Million Stock Position in STERIS plc (NYSE:STE)

California Public Employees Retirement System boosted its holdings in shares of STERIS plc (NYSE:STE) by 1.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 180,934 shares of the medical equipment provider’s stock after buying an additional 2,167 shares during the period. California Public Employees Retirement System owned approximately 0.18% of STERIS worth $39,778,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of the business. Millburn Ridgefield Corp acquired a new position in STERIS in the 3rd quarter worth about $25,000. Catalyst Capital Advisors LLC acquired a new position in STERIS in the 3rd quarter worth about $25,000. Global Wealth Management Investment Advisory Inc. acquired a new position in STERIS in the 3rd quarter worth about $49,000. NBC Securities Inc. acquired a new position in STERIS in the 3rd quarter worth about $50,000. Finally, Exchange Traded Concepts LLC acquired a new position in STERIS in the 3rd quarter worth about $54,000. 94.69% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

STE has been the topic of several research reports. JMP Securities reaffirmed a “market outperform” rating and issued a $265.00 target price on shares of STERIS in a research report on Thursday, February 8th. KeyCorp initiated coverage on STERIS in a report on Tuesday, February 6th. They set an “overweight” rating and a $253.00 price objective on the stock. Stephens reissued an “overweight” rating and set a $250.00 price objective on shares of STERIS in a report on Friday, February 9th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a report on Friday, April 12th. Finally, TheStreet raised STERIS from a “c+” rating to a “b” rating in a report on Wednesday, February 7th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $239.60.

STERIS Price Performance

Shares of NYSE:STE opened at $203.90 on Friday. The business has a 50 day moving average price of $221.18 and a 200 day moving average price of $216.80. STERIS plc has a twelve month low of $181.78 and a twelve month high of $254.00. The company has a market cap of $20.15 billion, a price-to-earnings ratio of 35.71 and a beta of 0.79. The company has a quick ratio of 1.49, a current ratio of 2.43 and a debt-to-equity ratio of 0.50.

STERIS (NYSE:STE) last announced its earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share for the quarter, beating the consensus estimate of $2.17 by $0.05. STERIS had a return on equity of 13.67% and a net margin of 10.48%. The firm had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter in the prior year, the company earned $2.02 EPS. The firm’s revenue for the quarter was up 14.8% compared to the same quarter last year. Research analysts predict that STERIS plc will post 8.67 earnings per share for the current year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Investors of record on Friday, February 23rd were paid a dividend of $0.52 per share. The ex-dividend date of this dividend was Thursday, February 22nd. This represents a $2.08 annualized dividend and a yield of 1.02%. STERIS’s payout ratio is 36.43%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.